The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Medical Costs of CKD in the Medicare Population
Open accessAbstract
Estimates of the medical costs associated with different stages of CKD are needed to assess the economic benefits of interventions that slow the progression of kidney disease. We combined laboratory data from the National Health and Nutrition Examination Survey with expenditure data from Medicare claims to estimate the Medicare program's annual costs that were attributable to CKD stage 1-4. The Medicare costs for persons who have stage 1 kidney disease were not significantly different from zero. Per person annual Medicare expenses attributable to CKD were $1700 for stage 2, $3500 for stage 3, and $12,700 for stage 4, adjusted to 2010 dollars. Our findings suggest that the medical costs attributable to CKD are substantial among Medicare beneficiaries, even during the early stages; moreover, costs increase as disease severity worsens. These cost estimates may facilitate the assessment of the net economic benefits of interventions that prevent or slow the progression of CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Estimating log models: to transform or not to transform?
Manning, W. G., & Mullahy, J. (2001) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00086-8 · Cited by 1,790
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Too much ado about two-part models and transformation?
Buntin, M. B., & Zaslavsky, A. M. (2004) · Journal of Health Economics · doi:10.1016/j.jhealeco.2003.10.005 · Cited by 732
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y., & Hendriksen, S. M. (2008) · Annals of Internal Medicine · Cited by 394
The Direct Medical Cost of Type 2 Diabetes
Brandle, M., Zhou, H., Smith, B. R. K., Marriott, D., Burke, R., Tabaei, B. P., Brown, M. B., & Herman, W. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2300 · Cited by 269
Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
Dalrymple, L. S., Katz, R., Kestenbaum, B., Shlipak, M. G., Sarnak, M. J., Stehman-Breen, C., Seliger, S., Siscovick, D., Newman, A. B., & Fried, L. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1511-x · Cited by 262
Prevalence of Chronic Kidney Disease and Associated Risk Factors—United States, 1999-2004
(2007) · JAMA · doi:10.1001/jama.297.16.1767 · Cited by 254
Smith, D. H., Gullion, C. M., Nichols, G., Keith, D. S., & Brown, J. B. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000125670.64996.bb · Cited by 187
Failure of ICD‐9‐CM Codes to Identify Patients with Comorbid Chronic Kidney Disease in Diabetes
Kern, E. F. O., Maney, M., Miller, D. R., Tseng, C., Tiwari, A., Rajan, M., Aron, D., & Pogach, L. (2006) · Health Services Research · doi:10.1111/j.1475-6773.2005.00482.x · Cited by 165
Comparing Cost‐of‐Illness Estimates from Alternative Approaches: An Application to Diabetes
Honeycutt, A., Segel, J. E., Hoerger, T. J., & Finkelstein, E. A. (2008) · Health Services Research · doi:10.1111/j.1475-6773.2008.00909.x · Cited by 63
Self-citationNationally Representative Medical Costs of Diabetes by Time Since Diagnosis
Trogdon, J. G., & Hylands, T. (2008) · Diabetes Care · doi:10.2337/dc08-1375 · Cited by 54
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Acute kidney injury-epidemiology, outcomes and economics
Rewa, O., & Bagshaw, S. M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.282 · Cited by 734
A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome
Sadowski, C. E., Lovric, S., Ashraf, S., Pabst, W. L., Gee, H. Y., Kohl, S., Engelmann, S., Vega-Warner, V., Fang, H., Halbritter, J., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050489 · Cited by 651
Metadata
- Authors
- Honeycutt, A. A., Segel, J. E., Zhuo, X., Hoerger, T. J., Imai, K., & Williams, D.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2013-09
- Volume
- 24
- Issue
- 9
- Pages
- 1478-1483
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2165401602
- Cited by
- 261
- References
- 14
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.